Adenosina Kabi

Adenosina Kabi is a pharmaceutical product containing adenosine, used for specific medical conditions. This intravenous medication is manufactured by Fresenius Kabi Italia S.R.L. and is designed for precise therapeutic applications.

Adenosina Kabi, containing the active ingredient adenosine, is primarily used for certain cardiac conditions. It is often administered intravenously to address specific heart rhythm issues. The medication works by affecting the electrical activity of the heart, helping to restore normal rhythms. Adenosine is commonly used in clinical settings to manage supraventricular tachycardia, a type of rapid heart rate.

When administered, Adenosina Kabi may cause a brief slowing of the heart rate, which is a common effect of adenosine. Some individuals may experience flushing, shortness of breath, or chest discomfort. These effects are typically short-lived and subside quickly. The medication is designed to have a rapid onset and short duration of action.

Adenosina Kabi should be handled with care and administered by healthcare professionals. It is important to follow proper procedures for intravenous use to ensure safety. Patients with certain heart conditions or allergies to adenosine should exercise caution. Always consult a healthcare provider for personalized advice.

Adenosina Kabi may interact with other medications, particularly those that affect heart rhythm or blood pressure. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Certain substances, such as caffeine or other stimulants, may also affect the efficacy of adenosine.